KING Co., Ltd.
KING Co., Ltd. (8118.T) Financial Performance & Income Statement Overview
Analyze KING Co., Ltd. (8118.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
KING Co., Ltd. (8118.T) Income Statement & Financial Overview
View the income breakdown for KING Co., Ltd. 8118.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.06B | $2.23B | $2.00B | $1.88B |
| Cost of Revenue | $849.00M | $988.00M | $989.00M | $742.00M |
| Gross Profit | $1.21B | $1.24B | $1.007B | $1.14B |
| Gross Profit Ratio | $0.59 | $0.56 | $0.50 | $0.61 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $980.00M | $939.00M | $983.00M | $919.00M |
| Operating Expenses | $980.00M | $939.00M | $983.00M | $921.00M |
| Total Costs & Expenses | $1.83B | $1.93B | $1.97B | $1.66B |
| Interest Income | $6.00M | $5.00M | $2.00M | $0.00 |
| Interest Expense | $2.00M | $1.00M | $0.00 | $0.00 |
| Depreciation & Amortization | $96.00M | $104.25M | $99.00M | $104.25M |
| EBITDA | $322.00M | $402.25M | $122.00M | $323.25M |
| EBITDA Ratio | $0.16 | $0.18 | $0.06 | $0.17 |
| Operating Income | $227.00M | $298.00M | $24.00M | $217.00M |
| Operating Income Ratio | $0.11 | $0.13 | $0.01 | $0.12 |
| Other Income/Expenses (Net) | -$3.00M | $38.00M | $95.00M | $37.00M |
| Income Before Tax | $224.00M | $336.00M | $119.00M | $254.00M |
| Income Before Tax Ratio | $0.11 | $0.15 | $0.06 | $0.14 |
| Income Tax Expense | $74.00M | $108.00M | -$82.00M | $101.00M |
| Net Income | $150.00M | $228.00M | $202.00M | $153.00M |
| Net Income Ratio | $0.07 | $0.10 | $0.10 | $0.08 |
| EPS | $9.38 | $14.25 | $12.64 | $9.58 |
| Diluted EPS | $9.38 | $14.25 | $12.64 | $9.58 |
| Weighted Avg Shares Outstanding | $15.99M | $16.00M | $15.98M | $15.97M |
| Weighted Avg Shares Outstanding (Diluted) | $15.99M | $16.00M | $15.98M | $15.97M |
Over the past four quarters, KING Co., Ltd. demonstrated steady revenue growth, increasing from $1.88B in Q1 2024 to $2.06B in Q4 2024. Operating income reached $227.00M in Q4 2024, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $322.00M, reflecting operational efficiency. Net income dropped to $150.00M, with EPS at $9.38. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan